Mindray, a global developer of innovative ultrasound solutions, will unveil a new product and highlight its flagship Resona 7 Ultrasound System at RSNA 2019.

From pediatric to geriatric, and vascular to radiology, Mindray’s comprehensive suite of ultrasound machines aligns with the clinical and financial goals of a diverse range of ultrasound practices. Visit exhibit #8121 at RSNA 2019 to see all that Mindray has to offer.

MAHWAH, N.J. (PRWEB)
November 21, 2019

Mindray, a global leader in the development of ultrasound machines and technologies, will attend the Radiological Society of North America’s (RSNA) 105th Scientific Assembly and Annual Meeting, December 1–6, at McCormick Place in Chicago, exhibit #8121. While there, Mindray will unveil its newest product and highlight its diverse portfolio of radiological ultrasound solutions.

Through concentrated efforts to bring their ultrasound technologies to the forefront of the space, Mindray prepares to head to RSNA following a string of milestone successes. These include the sale of their 100th Resona 7 System in North America and a partnership with Cincinnati Children’s Hospital Medical Center, one of the top children’s hospitals in the United States, according to U.S. News and World Report 2019-2020.

“As a leading developer of healthcare technology, Mindray is continually pushing towards our vision of better healthcare for all,” said Maher Elhihi, Director of Marketing for Mindray North America Ultrasound. “As the pressure continues to mount for our partners to cut costs and improve outcomes, we come through with unique and innovative solutions that enable clinicians to remain at the cutting-edge of ultrasound imaging for years to come. Our Living Technology™ and five-year warranty offer investment protection and ensure that our partners will not be left behind. In today’s rapidly changing technological landscape, that is a powerful proposition to bring forward.”

The following systems will be highlighted in Mindray exhibit #8121 and feature live scanning throughout the meeting:

• 
  Powered by the industry’s first virtual beamforming architecture, ZONE Sonography® Technology+ (ZST+), the Resona 7 System creates a perfectly focused image every pixel, every frame, every time. From skin line to deepest depths (up to 40 cm), the Resona 7 System is ideal for general imaging, vascular, women’s imaging and pediatric applications.
• Also powered by ZST+, the ZS3 System optimizes workflow with a new user interface design and enables premium clinical solutions, such as Acoustic Radiation Force Impulse (ARFI) Imaging and CEUS, in a highly portable system. The combination of premium performance and mobility is highly suited for demanding imaging environments.
• The TE7 System features eSpacial Navi™, a 4D magnetic needle navigation technology, delivering enhanced needle visualization for improved physician confidence and patient safety during interventional procedures.

From pediatric to geriatric, and vascular to radiology, Mindray’s comprehensive product suite aligns with the clinical and financial goals of a diverse range of ultrasound practices. Visit exhibit #8121 at RSNA 2019 to see all that Mindray has to offer.

About Mindray

Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California, with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email: